ICOSAVAX, INC. Proceeds from Common Stock Issued
ICOSAVAX, INC. reported Proceeds from Common Stock Issued of $67.48 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-11-14
- ICOSAVAX, INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was -$269.00K.
- ICOSAVAX, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $9.41M.
- ICOSAVAX, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- ICOSAVAX, INC. proceeds from issuance of common stock for fiscal 2022 was $9.41M.
- ICOSAVAX, INC. proceeds from issuance of common stock for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $67.48M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $67.75M 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $9.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $9.41M derived: sum of 2 quarters · filed 2023-11-14 | $9.41M 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |